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Doktor nauk medycznych Paweł Krzesiński jest absolwentem Wydziału Wojskowo-Lekarskiego 
Uniwersytetu Medycznego w Łodzi. W 2012 roku uzyskał tytuł specjalisty chorób wewnętrz-
nych, a obecnie odbywa szkolenie specjalizacyjne w dziedzinie kardiologii w Klinice Kardiologii 
i Chorób Wewnętrznych Wojskowego Instytutu Medycznego.
Nurt jego zainteresowań naukowych wiąże się ściśle z codzienną praktyką kliniczną i dotyczy 
zastosowania nieinwazyjnych metod diagnostycznych, takich jak kardiografia impedancyjna, 
tonometria aplanacyjna i ocena funkcji śródbłonka, w optymalizacji leczenia osób z chorobami 
kardiologicznymi. Czas wolny poświęca podróżom i literaturze.
Abstract
Introduction. The arterial stiffness has become the target of therapeutic interventions in patients with cardiovascular 
diseases and the ability to characterize and quantify arterial properties turned out to be of importance. Aim of this study 
was to evaluate the association of arterial stiffness and peripheral blood flow with clinical characteristics and hemody-
namics in patients with arterial hypertension (AH).
Material and methods. The study included 150 patients (111 men; mean age 43.5 years) with AH that underwent 
clinical evaluation and hemodynamic assessment by impedance plethysmography (IPG) and cardiography (ICG), with 
analysis of i.e. pulse wave velocity (PWV), mean arterial pressure (MAP), heart rate (HR), stroke index (SI), total artery 
compliance (TAC), systemic vascular resistance (SVRI), pre-ejection period (PEP) and left ventricular ejection time (LVET). 
Results. In comparative analysis PWV was significantly higher in women than men (6.18 ± 0.77 vs 5.91 ± 0.99 m/s; 
p = 0.035). PWV was also associated with age (R = 0.41), MAP (R = 0.32), HR (R = 0.32), SI (R = –0.47), arterial ela-
sticity (TAC, R = –0.31), vascular resistance (SVRI, 0.38) and sub-periods of heart contraction (PEP, R = 0.59 and LVET, 
0.28). Age, MAP, PEP and LVET revealed to be the independent covariates in the multivariate regression model for PWV 
estimation (R square 0.61).
Conclusions. Bioimpedance methods are complementary for the assessment of complexity of the arterial stiffness. PWV 
revealed to be associated with hemodynamic parameters characterizing ventricular-vascular interactions, including BP, 
SVRI, TAC, and characteristics of left ventricle performance (HR, SI, PEP, LVET). In view of the classifying value of PWV in 
cardiovascular risk evaluation the current patient’s hemodynamic state should be carefully considered.
Key words: arterial hypertension, arterial stiffness, impedance plethysmography, impedance cardiography, pulse wave 
velocity
(Folia Cardiologica 2015; 10, 1: 1–8)
2Folia Cardiologica 2015, tom 10, nr 1
www.fc.viamedica.pl
Introduction
Impaired arterial compliance is one of the main pathophy-
siological features influencing cardiovascular risk indepen-
dent from traditional risk factors. In young healthy people 
arteries are naturally compliant and respond to different 
clinical and physiological factors assuring optimal perfu-
sion that is dependent on the adequate flow parameters 
such us blood pressure, volume and its local distribution. 
The adaptation ability of arterial tree decreases with age, 
especially in presence of metabolic disturbances, arterial 
hypertension (AH) and smoking [1–4]. Therefore, the 
arterial stiffness has become the target of therapeutic 
interventions in patients with cardiovascular diseases and 
the ability to characterize and quantify arterial properties 
turned out to be of importance. Various non-invasive as-
sessment techniques have been developed to evaluate 
central and peripheral flow. Some markers of arterial 
remodeling and stiffness such as intima-media thickness 
and pulse wave velocity (PWV) are recognized as indepen-
dent risk factors and recommended to be implemented in 
clinical diagnostics [5]. These methods are easy to perform 
but more difficult to interpret because characteristics of 
blood flow depend not only on properties of local arteries 
but also forward and reflected waves interacting at each 
level of vasculature.
Impedance plethysmography (IPG) is one of the methods 
perceived as useful in non-invasive evaluation of periphe-
ral vessels based on the assessment of changes in local 
tissue electrical properties, mostly deriving from changes 
in blood volume [6]. It may be performed simultaneously 
with impedance cardiography (ICG) estimating hemody-
namic parameters such as i.e. stroke index (SI), cardiac 
index (CI), systemic vascular index (SVRI) and total artery 
compliance (TAC) [7, 8]. The multiparametric hemodynamic 
assessment enables the possibility to confront peripheral 
flow with other hemodynamic parameters and indicate its 
potential relations.
The aim of this study was to evaluate the nature of asso-
ciation of PWV assessed by IPG with clinical characteristics 
and other hemodynamic parameters in patients with AH.
Material and methods
Study population
This study included 150 patients (111 men; mean age 
43.5 ± 10.6 years) with at least 3-month history of AH 
(grade 1 and 2) defined according to European Society of 
Cardiology (ESC)/European Society of Hypertension (ESH) 
guidelines [5]. Exclusion criteria comprised: (1) confirmed 
secondary AH, (2) AH treated with three or more medicines 
before recruitment, (3) heart failure, (4) cardiomyopathy, 
(5) significant heart rhythm disorders, (6) significant valvu-
lar disease, (7) impaired renal function (GFR below 60 ml/ 
/min/1.73 m2), (8) chronic obstructive pulmonary disease, 
(9) diabetes, (10) polyneuropathy, (11) peripheral vascular 
disease, (12) age < 18 years and > 65 years. Patients 
treated with hypotensive drugs before recruitment (n = 29, 
19.3%) were recommended to discontinue pharmacothe-
rapy 7 days before examination.
The group selected to the analysis comprised patients 
with AH from two clinical studies performed from March 
2008 to May 2012. Both studies were conducted according 
to Good Clinical Practice guidelines and the Declaration of 
Helsinki, with the approval of local ethics committee. Each 
patient provided written informed consent to participate in 
the study. Demographic and clinical characteristics of the 
study group are shown in Table 1.
Clinical examination
Clinical examination was performed with special conside-
ration of familiar history of AH, cardiovascular risk factors 
and symptoms indicating secondary cause of AH. Office 
blood pressure measurement (Omron M4 Plus, Japan) was 
performed by technique compliant with the ESC guideli-
nes [5]. Laboratory tests included i.e. evaluation of renal 
function (creatinine, glomerular filtration rate calculated 
Table 1. Basic clinical characteristics of study group
Parameter Study group  
(n =150)
Men, n (%) 111 (74.0)
Age (years), mean ± SD 43.5 ± 10.6
Height [cm], mean ± SD 174.1 ± 9.0
Weight [kg], mean ± SD 88.9 ± 16.1
BMI [kg/m2], mean ± SD 29.2 ± 4.1
Office SBP [mm Hg], mean ± SD 146.5 ± 13.8
Office DBP [mm Hg], mean ± SD 93.9 ± 8.5
24-hour mean SBP [mm Hg], mean ± SD 139.6 ± 10.4
24-hour mean DBP [mm Hg], mean ± SD 87.3 ± 8.4
daytime mean SBP [mm Hg], mean ± SD 144.0 ± 10.6
daytime mean DBP [mm Hg], mean ± SD 90.9 ± 8.8
night-time mean SBP [mm Hg], mean ± SD 127.7 ± 12.1
night-time mean DBP [mm Hg], mean ± SD 77.6 ± 9.1
HR (bpm), mean ± SD 70.5 ± 10.2
Smoking, n (%) 34 (22.7)
Family history of AH, n (%) 72 (48.0)
Left ventricular hypertrophy, n (%) 29 (19.3)
Impaired relaxation of left ventricle, n (%) 34 (22.7)
Creatinine [μmol/dl], mean ± SD 75.8 ± 12.4
GFR [ml/min/1.73 m2], mean ± SD 99.6 ± 18.6
SD — standard deviation; BMI — body mass index; SBP — systolic blood pressure; DBP — diastolic 
blood pressure; HR — heart rate; AH — arterial hypertension; GFR — glomerular filtration rate
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using the Modification of Diet in Renal Disease [MDRD]) 
and metabolic disturbances.
Ambulatory blood pressure monitoring
Ambulatory blood pressure monitoring (ABPM) was per-
formed to verify the diagnosis of AH (Spacelabs 90207, 
Spacelabs, Medical Inc, Redmond, USA). Time from 6 a.m. 
to 10 p.m. was considered daily activity period (daytime) 
with automatic blood pressure measurement in 10-minute 
intervals. During night rest (night-time: 10 p.m.–6 a.m.) 
the measurement was performed every 30 minutes. The 
patients were recommended to adjust their circadian acti-
vity to those periods of time. The minimum correctness of 
BP measurement was defined as 70% for both daytime 
and night-time. Test results were interpreted according to 
European Society of Cardiology guidelines [5].
Impedance cardiography  
and impedance plethysmography
All measurements were performed using the Niccomo™ 
device (Medis, Ilmenau, Germany) with registration of im-
pedance signals of central (ICG, impedance cardiography) 
and peripheral (IPG, impedance plethysmography) flow 
assessed on left thigh as presented on Figure 1. Data 
was recorded in a quiet room after minimum 10 minutes 
of rest in a supine position and exported to a dedicated 
software (Niccomo Software, Ilmenau, Germany). The 
simultaneous registration of ICG and IPG curves enabled 
the calculation of pulse wave propagation parameters 
(Figure 2).
The final analysis included mean values of hemodyna-
mic parameters calculated from 10-minute long recording:
1) basal hemodynamic parameters: systolic blood pres-
sure (SBP, [mm Hg]); diastolic blood pressure (DBP, 
[mm Hg]); mean blood pressure (MBP, [mm Hg]); pulse 
pressure (PP, [mm Hg]); heart rate (HR, [bpm]);
2) ICG parameters: sub-periods of cardiac contraction 
— pre-ejection period (PEP [ms]) and left ventricular 
ejection time (LVET [ms]); stroke index (SI [ml/m2]), 
calculated using the Sramek and Bernstein formula SI = 
VEPT × dZmax × LVET /[Z0] × [BSA], accounting for weight, 
height and gender (variable VEPT), the amplitude of the 
systolic wave of the ICG (dZmax), LVET and body surface 
area (BSA); cardiac index (CI [ml/m2/min]), calculated 
as CI = SI × HR; systemic vascular resistance index 
(SVRI, [dyn × s × m2/cm5]); SVRI = 80 × [MAP-CVP]/[CI], 
where CVP is central venous pressure (assumed value 
6 mm Hg); total arterial compliance (TAC, [ml/mm Hg]), 
TAC = SV/[PP];
3) IPG parameters: heart to femoral pulse wave velocity 
(PWV [m/s]) calculated from the formula PWV = [elec-
trode distance]/[PT], where electrode distance was 
calculated with estimation of length of the thoracic 
aorta as 0.2 × [height] and pulse wave propagation time 
(PT [ms]) was the time from the opening of the aortal 
valve to the beginning of the systolic wave slope in the 
plethysmogram.
Echocardiography
Two-dimensional echocardiography was performed using 
standard parasternal, apical, and subcostal views (VIVID 4 
and VIVID 7 GE Medical System, 2.5 MHz transducer). The 
left ventricular hypertrophy was diagnosed according to the 
ASE-recommended formula for estimation of LV mass from 
2D linear LV measurements and indexed to body surface 
area (cut-off values for men LVMI > 115 g/m2, for women 
> 95 g/m2). The assessment of diastolic dysfunction was 
performed according to current guidelines [9, 10].
Statistical analysis
The statistical analysis of the results was performed using 
Statistica 7.0 (StatSoft, Inc.). The distribution and normality 
of data were assessed by visual inspection and using the 
Shapiro-Wilk test. Continuous variables were presented as 
means ± standard deviations (SD) and categorical variab-
les as absolute and relative frequencies (percentages). Figure 1. The location of IPG electrodes on patient’s leg
ICG 
IPG 
Propagation time Crest time
Figure 2. The scheme describing impedance cardiography (ICG) 
and IPG (impedance plethysmography) curves and calculation of 
propagation time
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Assessment of the relations between hemodynamic para-
meters was performed using univariate regression. Then, 
the most correlated and representative variables (age, sex, 
body mass index, MAP, PEP, SI, SVRI, TAC, LVET, PEP) were 
included into multivariate regression models to identify 
the independent covariates of PWV variance. A p value of 
< 0.05 was taken to indicate statistical significance.
Results
Hemodynamic characteristics of the study group are pre-
sented in Table 2.
In comparative analysis PWV was significantly higher 
in women than men (6.18 ± 0.77 vs 5.91 ± 0.99 m/s, 
p = 0.035). Smoking status has no significant influence 
on and PWV (6.03 ± 0.94 vs 5.83 ± 0.97 m/s, p = 0.410).
Univariate regression
In the univariate linear regression analysis the clearest 
correlations were observed for PWV with age, SI, SVRI, HR, 
MAP and PEP. Distinctly weaker correlations were found for 
the other analyzed parameters (Figure 3, Table 3).
Multivariate regression
In the multiple regression model the most representative 
basal characteristics, that can be easily estimated in office 
(age, HR and MAP), explained 27% variance of PWV:
[PWV] = 0.587 + 0.030 × [age] + 0.025 × [HR] +  
+ 0.023 × [MAP] (R squared value of 0.27).
However, the model including the most representative 
ICG parameters (SI, SVRI, TAC, PEP and LVET) provided ad-
ditional independent covariates and significantly increased 
explanatory value of the formula (R squared value of 0.61):
[PWV] = 2.068 + 0.035 × [age] + 0.029 × [MAP] –  
– 0.009 × [LVET] + 0.025 × [PEP] (HR was not included 
in the model because of redundancy with LVET and PEP).
Thus, the multivariate regression model revealed 
that PWV depends mostly on modifiable hemodynamic 
variables.
Discussion
In recent years the idea of evaluation of vessels has been 
emerging from the shadow of the heart muscle imaging. 
Our study was aimed to assess the relation of arterial 
stiffness to the general hemodynamic state. We focused 
on the identification of determinants of pulse wave pro-
pagation and velocity because the arising awareness of 
important interaction between heart and vessels imposed 
the evaluation of arterial properties together with cardiac 
function [11]. The presented results proved that such 
approach has important pathophysiological and clinical 
implications.
Arterial stiffness and wave reflection phenomenon 
were identified as important cardiovascular risk factors 
in patients with i.e. hypertension, diabetes mellitus and 
renal disease. In recent years the evaluation of arterial 
stiffness has been transferred from research field to cli-
nical cardiological practice. PWV is a well known, simple 
and reproducible method characterizing spreading pulse 
wave (but not flow volume) in arterial tree. The gold stan-
dard is carotid-femoral PWV (cfPWV) that revealed to be 
the independent predictor of the cardiovascular events. 
The additive value of PWV above traditional risk factors 
has been well quantified [5, 12]. The impedance plethy-
smography — the method we used for PWV assessment 
— revealed to be useful in some clinical applications. Bo-
duła et al. [13] used IPG in the assessment of the effect 
of pharmacotherapy (pentoxyphylline and suledoxide) in 
patients with lower limb ischemia. Irzmańska et al. [14] 
evaluated IPG assessing local blood flow in immobilized 
patients endangered with decubitus ulcer. They concluded 
that this simple non-invasive method can be useful in repe-
atable monitoring of peripheral flow not only in extremities 
but also in the trunk compartment.
In our study pulse wave propagation was associated 
with non-modifiable variables such as age, gender and 
anthropometrics. The strongest independent covariate in 
multiple regression models was age. This observation has 
its pathophysiological explanation. Arterial remodeling 
with aging is related to the structural changes in media 
and intima caused by elastic fibres destruction accompa-
nied with collagen and calcium deposition. Stiffer arteries 
can dilate to compensate the loss of compliance but 
Table 2. Hemodynamic characteristics of the study group
Parameter Study group (n =150)
SBP [mm Hg], mean ± SD 137.0 ± 11.9
DBP [mm Hg], mean ± SD 88.4 ± 7.9
MAP [mm Hg], mean ± SD 100.5 ± 8.6
PP [mm Hg], mean ± SD 48.6 ± 8.1
SVRI [dyn × s × m2/cm5], mean ± SD 2346.4 ± 473.5
HR [bpm], mean ± SD 70.5 ± 10.2
SI [ml/m2], mean ± SD 48.0 ± 8.8
CI [ml/m2/min], mean ± SD 3.33 ± 0.53
TAC [ml/mm Hg], mean ± SD 2.06 ± 0.50
LVET [ms], mean ± SD 318.6 ± 37.1
PEP [ms], mean ± SD 97.7 ± 17.5
PWV [m/s], mean ± SD 5.98 ± 0.94
SBP — systolic blood pressure; SD — standard deviation; DBP — diastolic blood pressure;  
MAP — mean arterial pressure; PP — pulse pressure; SVRI — systemic vascular resistance index; 
HR — heart rate; SI — stroke index; CI — cardiac index; TAC — total arterial compliance; LVET — left 
ventricular ejection time; PEP — pre-ejection period; PWV — pulse wave velocity
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this mechanism is insufficient to prevent hemodynamic 
consequences such as increase in SBP, PP and PWV [15]. 
Sex differences in peripheral flow were presented in detail 
by Albaladejo et al. [16] who examined large cohorts of 
women and men. Multiple regression revealed that in 
women PWV depended only on age and SBP (R square 
respectively 0.27 and 15.4). Mean additional covariates 
were weight and heart rate (R square for normotensives 
0.27, hypertensives — 0.29).
The relation of lower TAC and higher SVRI with higher 
PWV indicates high contribution of the central arterial 
compliance to the arterial stiffness. Ng et al. [17] reported 
the association of higher MAP and PWV with aortic wall 
degeneration in hypertensive rats. Observations in twin 
Figure 3. Correlation plots of pulse wave velocity (PWV) with age (A), mean arterial pressure (MAP) (B), heart rate (HR) (C), stroke index (SI) (D), 
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women revealed that increased PWV is related to aortic 
calcification (but not IMT and noncalcified atheromas) and 
strongly dependent on genetic factors [18]. Association of 
the increased PWV with thoracic artery calcification was 
confirmed in other studies [19, 20].
The observed independent relation of PWV to BP 
corresponds with the conclusions from the systematic 
review by Cecelja and Chowienczyk [21] and the study 
performed by Zheng and Murray [22] that examined the 
influence of change in BP on PWV in 100 healthy subjects 
in a controlled manner. They induced change in transmu-
ral pressure using long arm cuff inflated to maximum of 
40 mm Hg and observed that arterial distensibility was 
significantly related to resting BP and age. A reduction 
of transmural pressure by 40 mm Hg effected in signifi-
cant decrease of PWV (from 12 to 8 m/s). This trend was 
confirmed by our results where MAP revealed to be inde-
pendent covariate in the regression model. The second 
strong hemodynamic covariate that contributed to PWV 
was HR. Also Millasseau et al. [23] reported significant 
influence of provoked tachycardia on PWV and this effect 
was independent from BP, as in our study. Langham et 
al. [24] point that PWV can change from beat to beat 
because of the unstable arterial compliance associated 
with R-R interval variations. The significant relation of 
PWV with LVET supplemented the conclusions from cor-
Table 3. Correlations between pulse wave velocity (PWV) and 
other parameters
Parameter R p








SVRI 0.38 < 0.00001
HR 0.32 0.00008




PEP 0.59 < 0.00001
NS — non significant; BMI — body mass index; SBP — systolic blood pressure; DBP — diastolic 
blood pressure; MAP — mean arterial pressure; PP — pulse pressure; SVRI — systemic vascular 
resistance index; HR — heart rate; SI — stroke index; CI — cardiac index; TAC — total arterial com-
pliance; LVET — left ventricular ejection time; PEP — pre-ejection period
relation with HR. The shorter LVET the more increased 
central-to-peripheral pressure amplification resulting in 
the higher “functional” stiffness [15]. On the other hand, 
the correlation with PEP suggests that the isovolumetric 
contraction time is prolonged in subjects with higher PWV 
and the arterial stiffness influences the left ventricular 
performance. This phenomenon was also observed in 
other studies and corresponded with left diastolic dys-
function and ventricular hypertrophy [25–27].
Our observation suggests that the assessment of PWV 
as a predictive factor can be limited in some patients, 
especially those with mostly “functional” than structural 
cardiovascular disturbances. The regression models reve-
aled that the key determinants of PWV can be evaluated 
by simple clinical examination. However, the evaluation of 
arterial stiffness can definitely be more objective if LVET 
and PEP are known.
Being aware that the assessment of arterial stiffness 
could reclassify patient’s cardiovascular risk [5], we suggest 
the considered approach to the peripheral flow evaluation, 
especially PWV. Following ideas of other scientists [16] we 
suggest the PWV assessment after correcting hemodyna-
mic disturbances, especially abnormal BP and tachycardia. 
In this context increased stiffness in the presence of well 
controlled HR and BP should be interpreted as a worse 
arterial condition. In opinion of McEniery et al. [19] such 
observation may concern patients potentially more resi-
stant to the treatment.
The authors are aware that the small sample size 
limits the study. The method of PWV assessment used in 
this study (based on distance from ascending aorta to the 
peripheral artery) cannot be treated as equivocal to “gold 
standard” cervical-femoral PWV. Moreover, our observa-
tions are limited to untreated hypertensives without other 
clinically important cardiovascular diseases, therefore 
the results should be considered carefully as relating to 
a particular group of patients.
Conclusions
Impedance plethysmography and cardiography are com-
plementary methods for the assessment of cardiovascular 
system. The arterial stiffness revealed to be related to age, 
gender, anthropometrics and strongly associated with he-
modynamic profile. In view of the classifying value of PWV 
in cardiovascular risk evaluation it should be interpreted 
considering current hemodynamic state.
Conflicts of interest
The authors declare no conflicts of interest.
7www.fc.viamedica.pl
Paweł Krzesiński et al., Complexity of arterial stiffness in hypertension
Streszczenie
Wstęp. Sztywność naczyniowa jest obecnie celem interwencji terapeutycznych u pacjentów z chorobami układu sercowo-
-naczyniowego. Dlatego możliwość oceny właściwości układu naczyniowego okazuje się szczególnie istotna. Celem 
pracy była ocena charakteru powiązań prędkość fali tętna (PWV) z parametrami klinicznymi oraz hemodynamicznymi 
u chorych z nadciśnieniem tętniczym.
Materiał i metody. Analizą objęto grupę 150 pacjentów (w tym 111 mężczyzn; średni wiek 43,5 roku) z nadciśnieniem 
tętniczym, bez istotnych schorzeń współistniejących. U wszystkich badanych po wstępnej ocenie klinicznej wykonano 
10-minutową rejestrację parametrów hemodynamicznych metodami kardiografii (ICG) i pletyzmografii impedancyjnej 
z oceną między innymi PWV, średniego ciśnienia tętniczego (MAP), częstości rytmu serca (HR), wskaźnika wyrzutowego 
(SI), całkowitej podatności naczyniowej (TAC), wskaźnika systemowego oporu naczyniowego (SVRI), okresu przedwyrzu-
towego (PEP) i czasu wyrzutu z lewej komory (LVET).
Wyniki. Wartość PWV okazała się istotnie większa u kobiet niż u mężczyzn (6,18 ± 0,77 v. 5,91 ± 0,99 m/s; p = 0,035). 
W ocenie wzajemnych relacji wartość PWV najistotniej korelowała z wiekiem (R = 0,41), MAP (R = 0,32), HR (R = 0,32), 
SI (R = –0,47), TAC (R = –0,31), SVRI (R = 0,38) oraz podokresami skurczu serca: PEP (R = 0,59) i LVET (R = 0,28). 
W modelu wieloczynnikowym (R2 = 0,61) niezależnymi zmiennymi związanymi z PWV okazały się: wiek, MAP, PEP i LVET.
Wnioski. Metody bioimpedancyjne okazują się przydatne w ocenie złożonej natury sztywności naczyniowej. Prędkość 
fali tętna wykazuje powiązania z innymi parametrami hemodynamicznymi charakteryzującymi interakcję lewej komory 
mięśnia sercowego z układem naczyniowym, w tym najsilniejsze z ciśnieniem tętniczym (BP), SVRI, TAC oraz wskaźnika-
mi funkcji mięśnia sercowego jako pompy (HR, SI, PEP, LVET). Otrzymane wyniki wskazują, że wartość rokownicza PWV 
powinna być interpretowana z uwzględnieniem bieżącego stanu hemodynamicznego badanej osoby.
Słowa kluczowe: nadciśnienie tętnicze, sztywność naczyniowa, pletyzmografia impedancyjna, kardiografia impedancyjna, 
prędkość fali tętna
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W zaleceniach dotyczących leczenia nadciśnienia tętniczego podkreślono znaczenie nie-
inwazyjnych badań służących ocenie struktury i funkcji dużych tętnic [1]. Do tradycyjnych 
metod należy zaliczyć badanie ultrasonograficzne tętnic szyjnych (z pomiarem grubości 
kompleksu błony środkowej i wewnętrznej lub oceną obecności blaszek miażdżycowych) 
oraz wskaźnik kostka–ramię. Zmiany w tętnicach szyjnych są predyktorem zarówno 
udaru mózgu, jak i zawału serca. Niski wskaźnik kostka–ramię wskazujący na chorobę 
tętnic obwodowych i ogólnie na zaawansowaną zmiany miażdżycowe wiąże się z rozwo-
jem choroby wieńcowej, niewydolności serca oraz udaru mózgu.
W ostatnich latach obserwujemy stały wzrost zainteresowania znaczeniem sztywności 
dużych tętnic i zjawiska odbicia fali tętna. Wynika to z wielu przesłanek patofizjologicznych 
i klinicznych. Po pierwsze, pomiar prędkości fali tętna (PWV, pulse wave velocity) pozwala na całościową, nieinwazyjną 
ocenę sztywności tętnic. Po drugie, proces sztywnienia naczyń leży u postawy rozwoju izolowanego nadciśnienia skur-
czowego i wzrostu ciśnienia tętna. Nieproporcjonalny do wieku wzrost szybkości fali tętna jest uznawany za wykładnik 
„przedwczesnego starzenia się naczyń” (EVA, early vascular aging) [2, 3]. Po trzecie, sztywność dużych naczyń jest 
niezależnym czynnikiem ryzyka wystąpienia incydentów sercowo-naczyniowych u pacjentów z nadciśnieniem tętniczym. 
Dodana wartość PWV wykracza poza tradycyjne czynniki ryzyka ujęte w skalach SCORE (Systematic COronary Risk 
Evaluation) i Framingham [4–6]. Dodatkowo pomiar sztywności tętnic umożliwia reklasyfikację znacznego odsetka 
pacjentów z grupy pośredniego ryzyka do grupy większego lub mniejszego ryzyka sercowo-naczyniowego [4].
We wcześniejszych badaniach dowiedziono, że sztywność dużych naczyń jest związana z upośledzeniem funkcji 
małych naczyń [7] oraz wzrostem zmienności ciśnienia tętniczego [8]. Otwartym pytaniem pozostaje, czy odwrócenie 
sztywności naczyń może przynieść większe korzyści niż sama normalizacja ciśnienia tętniczego [9]. W nowatorskiej 
pracy Krzesińskiego i wsp. wykazano, że wartość PWV powinna być interpretowana z uwzględnieniem bieżącego sta-
nu hemodynamicznego badanego. Co więcej, metody bioimpedancyjne mogą być przydatne w ocenie mechanizmów 
odpowiedzialnych za występowanie sztywności naczyniowej. Wykorzystanie tych metod w przyszłych randomizowanych 
badaniach klinicznych może się przyczynić do precyzyjniejszej oceny związku sztywności naczyń z ryzykiem sercowo-
-naczyniowym, a co ważniejsze — do poznania optymalnych metod leczenia chorych z nadciśnieniem tętniczym.
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